ESAB Corporation is a global manufacturer of welding, cutting, and gas control equipment, consumables, and automation solutions. Founded in 1904 and spun off from Colfax in 2022, the company serves construction, shipbuilding, energy, infrastructure, automotive, and general manufacturing end markets through its Americas and EMEA & APAC segments. Its portfolio spans welding power sources, cutting machines, torches, electrodes, filler metals, and robotic and automated fabrication systems.
The company ranks among the leading players in welding technology, competing primarily with Lincoln Electric and the Miller brand of Illinois Tool Works. Investors follow ESAB closely for its shift toward higher-margin equipment and automation, its exposure to emerging markets such as India and the Middle East, and its disciplined acquisition strategy. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Over the last 30 days, ESAB shares moved from a closing price of $78.89 to $66.67, a decline of approximately 15.5%. The move was punctuated by a series of new 52-week lows in late August and September, with the stock trading beneath both its 50-day and 200-day moving averages.
The weakness is part of a broader trend. Measured from a mid-June closing level near $106, the stock has fallen roughly 37% over the trailing three-month period. The shares are now down more than 50% from their 52-week high of $137.42, reflecting a sustained re-rating of the stock's valuation multiples even as reported revenue has continued to grow. From what I see, this re-rating stands out given the underlying sales momentum.
The most consequential catalyst was the company's second-quarter report, released in early August. While revenue of $807.6 million beat consensus estimates and rose 12.9% year over year, adjusted earnings per share of $1.33 missed analysts' expectations by $0.04. Net income fell to $32.35 million from $66.88 million a year earlier, and operating margin contracted to 9.7% from 15.2%, raising concerns about profitability even as sales expanded.
Compounding the earnings miss, the early completion of the Eddyfi acquisition increased investor focus on the balance sheet. The transaction pushed pro forma net debt higher and raised leverage to roughly 3.3 times EBITDA, prompting analysts to highlight deleveraging as a near-term risk. Insider selling, reported at about $8.9 million over the prior twelve months, added to the cautious tone. I’m watching this closely as macroeconomic factors also contributed, including tariff-related uncertainty, rerouted logistics and higher freight costs tied to Middle East disruptions, and broader industrial-sector deleveraging.
The three-month decline reflects a shift in the market's emphasis from top-line growth to earnings quality and leverage. Earlier in the year, ESAB reported record first-quarter sales of $715 million and reaffirmed its outlook, supported by strong bookings and pricing actions. However, persistent margin compression, tariff headwinds, and the dilutive early phases of the Eddyfi integration gradually eroded confidence.
Management's decision to raise full-year 2026 guidance following the Eddyfi close, including adjusted EPS of $5.40 to $5.50 and adjusted EBITDA of $615 million to $625 million, was not enough to offset concerns that near-term profitability would remain under pressure. As the quarter progressed, the stock repeatedly set new lows, underscoring how cyclical, trade, and integration risks have come to dominate the narrative over shorter-term fundamentals.
Looking ahead, investors will be watching whether ESAB can convert record sales growth into margin recovery. The integration and deleveraging timeline following the Eddyfi acquisition remains a central focus, as does the company's progress toward its raised 2026 adjusted EBITDA and EPS targets. Upcoming quarterly results will provide an early read on whether price-cost pressures, logistics costs, and tariff-related volume headwinds are stabilizing. In my view, demand trends in key end markets, including energy, infrastructure, and industrial automation, along with the pace of recovery in emerging markets, will also shape sentiment. Any changes to analyst ratings or price targets, and the broader direction of industrial-sector valuations, may influence the stock's path. These factors should be evaluated as part of a broader investment review rather than as standalone signals.
When analyzing stocks like this, I often rely on Tickeron’s AI Daily Buy/Sell Signals to get a quick read on momentum and potential entry or exit points alongside traditional fundamentals. The platform helps surface patterns that might otherwise go unnoticed in volatile industrial names.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
The Aroon Indicator for ESAB entered a downward trend on September 17, 2026. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 146 similar instances where the Aroon Indicator formed such a pattern. In 97 of the 146 cases the stock moved lower. This puts the odds of a downward move at 66%.
The Moving Average Convergence Divergence Histogram (MACD) for ESAB turned negative on August 13, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 44 similar instances when the indicator turned negative. In 24 of the 44 cases the stock turned lower in the days that followed. This puts the odds of success at 55%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ESAB declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 63%.
The RSI Indicator shows that the ticker has stayed in the oversold zone for 6 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 13 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +1.42% 3-day Advance, the price is estimated to grow further. Considering data from situations where ESAB advanced for three days, in 196 of 273 cases, the price rose further within the following month. The odds of a continued upward trend are 72%.
ESAB may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron Valuation Rating of 36 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.746) is normal, around the industry mean (3.163). P/E Ratio (20.840) is within average values for comparable stocks, (31.021). Projected Growth (PEG Ratio) (0.650) is also within normal values, averaging (0.846). Dividend Yield (0.006) settles around the average of (0.015) among similar stocks. P/S Ratio (1.358) is also within normal values, averaging (5901.087).
The Tickeron PE Growth Rating for this company is 57 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 77 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 85 (best 1 - 100 worst), indicating slightly worse than average price growth. ESAB’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ESAB’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 74, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry MetalFabrication